Summary
General Electric (GE) reported a decline in consolidated revenues for the second quarter of 2019, primarily due to asset dispositions and foreign currency impacts. The company experienced a net loss of $0.01 per share on a consolidated basis. However, "adjusted" earnings per share, which excludes certain charges and gains, were $0.17. GE Industrial segment organic revenues saw an increase of 7%, driven by Renewable Energy, Oil & Gas, Aviation, and Healthcare. The company made significant progress in divesting non-core assets, including the spin-off of its Transportation segment and the agreement to sell its BioPharma business. Despite these divestitures, the company recognized a significant non-cash goodwill impairment charge of $0.7 billion in the Renewable Energy segment. The company's financial performance was impacted by various strategic actions, including the spin-off of Transportation to Wabtec and the pending sale of BioPharma. The Aviation segment remained a strong performer, while the Power segment continued to face challenges due to overcapacity and pricing pressure. GE's liquidity position remained solid with $20.1 billion in cash and cash equivalents at the end of the quarter. The company is focusing on deleveraging and operational improvements across its segments.
Financial Highlights
45 data points| Revenue | $23.41B |
| Cost of Revenue | $17.41B |
| Gross Profit | $6.00B |
| SG&A Expenses | $3.42B |
| Operating Expenses | $23.87B |
| Operating Income | $846.00M |
| Net Income | $127.00M |
| EPS (Basic) | $-0.08 |
| EPS (Diluted) | $-0.08 |
| Shares Outstanding (Basic) | 1.09B |
| Shares Outstanding (Diluted) | 1.09B |
Key Highlights
- 1Consolidated revenues decreased by 1% year-over-year to $28.8 billion, largely due to business dispositions and foreign currency headwinds.
- 2The company reported a net loss of $0.01 per share, but adjusted earnings per share (excluding certain items) was $0.17.
- 3GE Industrial segment organic revenues grew by 7%, indicating underlying strength in its core industrial businesses.
- 4Significant progress was made on strategic divestitures, including the spin-off of the Transportation segment to Wabtec and the agreement to sell the BioPharma business for $21.4 billion.
- 5A $0.7 billion non-cash goodwill impairment charge was recognized in the Renewable Energy segment, primarily impacting the Grid Solutions business.
- 6The Aviation segment showed resilience with segment profit of $1.4 billion, despite impacts from the Boeing 737 MAX grounding.
- 7GE's liquidity remains robust, with $20.1 billion in cash and cash equivalents as of June 30, 2019.